The Future of the FDA: What Comes Next?
Impossibile aggiungere al carrello
Puoi avere soltanto 50 titoli nel carrello per il checkout.
Riprova più tardi
Riprova più tardi
Rimozione dalla Lista desideri non riuscita.
Riprova più tardi
Non è stato possibile aggiungere il titolo alla Libreria
Per favore riprova
Non è stato possibile seguire il Podcast
Per favore riprova
Esecuzione del comando Non seguire più non riuscita
The Future of the FDA: What Comes Next?
-
Letto da:
-
Di:
A proposito di questo titolo
In this first of a 2-part series featuring Steve Usdin, Senior Editor, Washington, BioCentury Publications, host Jayson Slotnik, JD, MPH, Partner at Health Policy Strategies and AVBCC Board Member, leads a spirited conversation around developments at the FDA, the political influence shaping its decisions, and the outlook for the future.
Key topics covered include:
- The state of morale among FDA career staff and the challenges in attracting new talent
- Eroding confidence levels within the investor community and implications for funding
- Political and ideological influence on FDA activities
- The debate over the upcoming FDA commissioner appointment and potential candidates
- The significance of recent initiatives like Operation Trial Blazer in restoring confidence
- Opportunities for optimism with FDA’s recent engagement with rare disease advocates and international collaboration efforts
Resources & Links:
- BioCentury Publications
- Operation Trial Blazer
Connect with Our Guests:
- Connect with Steve Usdin
- Connect with Jayson Slotnik
Contact Value-Based Voices
- Follow AVBCC on LinkedIn
- View our podcast lineup
- Contact us at info@avbcc.org
Thanks for listening!
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione